fampridine News
Most Popular fampridine Story
Acorda shares soar after FDA panel backs MS drug
A panel of FDA experts had no trouble overcoming the concerns of regulators when they voted to approve Acorda Therapeutics' new drug to improve the ability of multiple sclerosis patients to walk. The Read more...
Latest Headlines
- October 15, 2009
- October 14, 2009
- October 9, 2009
- July 1, 2009
- April 23, 2009
- March 31, 2009
- February 27, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
